Literature DB >> 29203189

Inhibition of Jun N-terminal Kinase Improves Erectile Function by Alleviation of Cavernosal Apoptosis in a Rat Model of Cavernous Nerve Injury.

Juhyun Park1, Ji Sun Chai2, Soo Woong Kim2, Jae-Seung Paick2, Min Chul Cho3.   

Abstract

OBJECTIVE: To determine whether Jun N-terminal kinase (JNK) inhibition could alleviate erectile dysfunction (ED) through suppressing cavernosal apoptosis in a rat model of carvernosal nerve crush injury (CNCI), thereby providing potential therapeutic strategy for alleviating postradical prostatectomy ED.
MATERIALS AND METHODS: Fifty-six 11-week-old male Sprague-Dawley rats were categorized equally into the following 4 groups: (1) sham surgery (S), (2) CNCI (I), (3) CNCI treated with low-dose JNK inhibitor (L), and (4) CNCI treated with high-dose JNK inhibitor (H). The L and H groups received daily intraperitoneal injection of JNK inhibitors (1.0 mg/kg for the L group and 10.0 mg/kg for the H group) for 2 weeks starting from the following day after surgery. Erectile response, Western blot, and immunohistochemistry were assessed.
RESULTS: At 2 weeks after surgery, intracavernous pressure-mean arterial pressure and area under the curve-mean arterial pressure in group I were significantly decreased compared with those in group S. Erectile responses in group H were significantly improved compared with those in group I. Group I showed decreased smooth muscle (SM) content, increased apoptosis, increased apoptotic or SM cells positive for phosphorylated c-Jun, increased c-Jun phosphorylation, and decreased Bcl2-to-Bax ratio compared with group S. Group H showed significant improvements in histologic alterations and dysregulation of the JNK-driven pathway.
CONCLUSION: Our data suggest that JNK inhibition can improve erectile function by alleviating cavernosal apoptosis through restoring the JNK-related pathway toward normal. Thus, an early therapeutic strategy targeting the JNK pathway might be able to alleviate cavernosal SM apoptosis and postradical prostatectomy ED caused by cavernous nerve injury.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29203189     DOI: 10.1016/j.urology.2017.11.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  [Exogenous hydrogen sulfide improves erectile dysfunction by inhibiting apoptosis of corpus cavernosum smooth muscle cells in rats with cavernous nerve injury].

Authors:  Qinyu Zeng; Shuhua He; Liren Zhong; Li Wang; Fengzhi Cheng; Haibo Zhang; Jialiang Hui; Anyang Wei
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

2.  Effect of Asthma on Erectile Dysfunction in Rats as Determined by Biological Network Analysis.

Authors:  Jisheng Wang; Xuefeng Gong; Sheng Deng; Fanchao Meng; Hengheng Dai; Binghao Bao; Junlong Feng; Haisong Li; Bin Wang
Journal:  Med Sci Monit       Date:  2020-12-20

3.  Potential mechanism of Achyranthis bidentatae radix plus semen vaccariae granules in the treatment of diabetes mellitus-induced erectile dysfunction in rats utilizing combined experimental model and network pharmacology.

Authors:  Ji-Sheng Wang; Jun-Long Feng; Heng-Heng Dai; Zi-Long Chen; Xiao Li; Bing-Hao Bao; Sheng Deng; Fan-Chao Meng; Qi Zhao; Hong-Sheng Xu; Bin Wang; Hai-Song Li
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  Combination Therapy with a JNK Inhibitor and Hepatocyte Growth Factor for Restoration of Erectile Function in a Rat Model of Cavernosal Nerve Injury: Comparison with a JNK Inhibitor Alone or Hepatocyte Growth Factor Alone.

Authors:  Junghoon Lee; Soo Woong Kim; Min Chul Cho
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

5.  Restoration of Cavernous Veno-Occlusive Function through Chronic Administration of a Jun-Amino Terminal Kinase Inhibitor and a LIM-Kinase 2 Inhibitor by Suppressing Cavernous Apoptosis and Fibrosis in a Rat Model of Cavernous Nerve Injury: A Comparison with a Phosphodiesterase Type 5 Inhibitor.

Authors:  Min Chul Cho; Junghoon Lee; Juhyun Park; Soo Woong Kim
Journal:  World J Mens Health       Date:  2020-07-09       Impact factor: 5.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.